Dual Channel

Aug

Improving Access to Innovative Drugs: Can China’s Dual-Channel Policy Deliver?

To tackle the hospital formulary access issues faced by some NRDL-negotiated drugs, the National Healthcare Security Administration (NHSA) introduced the

Aug 30, 2023

5 min read

Jul

Behind the Scenes: Exploring the Roadblocks to Formulary Listing for NRDL-Negotiated Drugs in China Public Hospitals

China's National Reimbursement Drug List (NRDL) is increasingly incorporating innovative drugs. Once included in the NRDL, these drugs

Jul 5, 2023

6 min read